Beijing Water Business Doctor Co., Ltd. (SHE:300055)
China · Delayed Price · Currency is CNY 7.79
-0.15 (-1.89%)
At close: Jan 30, 2026
SHE:300055 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 2,625 | 2,730 | 2,819 | 2,715 | 2,007 | 629.61 |
Other Revenue | 0.91 | 0.91 | 2.32 | 2.49 | 1.85 | 1.4 |
| 2,626 | 2,731 | 2,821 | 2,718 | 2,009 | 631.02 | |
Revenue Growth (YoY) | 7.47% | -3.21% | 3.82% | 35.25% | 218.43% | -24.89% |
Cost of Revenue | 2,359 | 2,529 | 2,662 | 2,427 | 1,630 | 474.1 |
Gross Profit | 267.38 | 201.56 | 159.47 | 290.41 | 379.53 | 156.91 |
Selling, General & Admin | 133.29 | 121.53 | 100.55 | 104.26 | 116.01 | 81.28 |
Research & Development | 35.53 | 41.43 | 59.27 | 99.49 | 72.06 | 15.44 |
Other Operating Expenses | 117.86 | 81.18 | 11.18 | 9.02 | 4.08 | -0.09 |
Operating Expenses | 268.28 | 232.43 | 214.52 | 265.67 | 178.89 | 633.49 |
Operating Income | -0.9 | -30.88 | -55.05 | 24.73 | 200.64 | -476.58 |
Interest Expense | -16.62 | -18.66 | -19.49 | -27.3 | -32.53 | -33.04 |
Interest & Investment Income | 41.32 | 44.21 | 46.62 | 50.95 | 117.4 | 129.06 |
Currency Exchange Gain (Loss) | 0.17 | 0.17 | -0.06 | 0.78 | -0.03 | - |
Other Non Operating Income (Expenses) | -23.01 | -17.26 | -61.21 | 67.23 | 2.47 | 0.45 |
EBT Excluding Unusual Items | 0.95 | -22.42 | -89.2 | 116.39 | 287.95 | -380.11 |
Gain (Loss) on Sale of Investments | 41.8 | 41.4 | -84.56 | 1.49 | - | - |
Gain (Loss) on Sale of Assets | -2.64 | -1.46 | 0.31 | -0.16 | 0.04 | 0.02 |
Asset Writedown | -0.67 | -0.67 | -37.72 | -6.62 | -1.89 | -41.63 |
Other Unusual Items | 7.85 | 7.85 | 9.14 | 5.71 | 9.77 | -0 |
Pretax Income | 47.3 | 24.69 | -202.02 | 116.82 | 295.87 | -421.72 |
Income Tax Expense | -28.68 | -20.24 | -16.08 | 10.59 | 20.51 | -45.43 |
Earnings From Continuing Operations | 75.98 | 44.93 | -185.94 | 106.24 | 275.36 | -376.29 |
Minority Interest in Earnings | -20.52 | -9.36 | -5.27 | -27.79 | -63.32 | 1.29 |
Net Income | 55.46 | 35.57 | -191.21 | 78.45 | 212.03 | -375 |
Net Income to Common | 55.46 | 35.57 | -191.21 | 78.45 | 212.03 | -375 |
Net Income Growth | - | - | - | -63.00% | - | - |
Shares Outstanding (Basic) | 837 | 837 | 834 | 803 | 829 | 865 |
Shares Outstanding (Diluted) | 837 | 837 | 834 | 803 | 829 | 865 |
Shares Change (YoY) | 0.57% | 0.36% | 3.85% | -3.13% | -4.20% | -0.04% |
EPS (Basic) | 0.07 | 0.04 | -0.23 | 0.10 | 0.26 | -0.43 |
EPS (Diluted) | 0.07 | 0.04 | -0.23 | 0.10 | 0.26 | -0.43 |
EPS Growth | - | - | - | -61.81% | - | - |
Free Cash Flow | -921.21 | -575.84 | -618.15 | 488.02 | -98.5 | -48.31 |
Free Cash Flow Per Share | -1.10 | -0.69 | -0.74 | 0.61 | -0.12 | -0.06 |
Dividend Per Share | 0.015 | 0.015 | 0.015 | - | 0.030 | 0.015 |
Dividend Growth | - | - | - | - | 100.00% | - |
Gross Margin | 10.18% | 7.38% | 5.65% | 10.69% | 18.89% | 24.87% |
Operating Margin | -0.03% | -1.13% | -1.95% | 0.91% | 9.99% | -75.52% |
Profit Margin | 2.11% | 1.30% | -6.78% | 2.89% | 10.55% | -59.43% |
Free Cash Flow Margin | -35.08% | -21.09% | -21.91% | 17.96% | -4.90% | -7.66% |
EBITDA | 170.52 | 130.62 | 93.22 | 182.7 | 347.13 | -402.34 |
EBITDA Margin | 6.49% | 4.78% | 3.30% | 6.72% | 17.28% | -63.76% |
D&A For EBITDA | 171.42 | 161.5 | 148.27 | 157.97 | 146.49 | 74.24 |
EBIT | -0.9 | -30.88 | -55.05 | 24.73 | 200.64 | -476.58 |
EBIT Margin | -0.03% | -1.13% | -1.95% | 0.91% | 9.99% | -75.52% |
Effective Tax Rate | - | - | - | 9.06% | 6.93% | - |
Revenue as Reported | 2,626 | 2,731 | 2,821 | 2,718 | 2,009 | 631.02 |
Advertising Expenses | - | 0.18 | 0.11 | 0.08 | 0.07 | 0.07 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.